Low Dose Aspirin Preeclampsia Prevention Campaign
OPQIC, OSDH and the George Kaiser Family Foundation have collaborated on a low-dose aspirin in pregnancy initiative to reduce the incidence and severity of preeclampsia in pregnant Oklahomans.
Click on the links below to access the toolkit.
Questions about this initiative?
Contact Melissa Warde at Melissa@okoha.com
Low Dose Aspirin Toolkit for Providers and Patients
In conjunction with the Oklahoma Health Care Authority, OPQIC led a provider/caregiver webinar on October 31, 2023. The recording link is available below, along with the slides from the webinar, and answers to the Q&A portion.
Webinar:
(3) Low dose Aspirin Initiative – YouTube
Slides:
OPQIC and George Kaiser Family Foundation (oklahoma.gov)
Q&A:
-
Instructions For Use -
-
-
-
-
-
- Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up – ScienceDirect
- ACOG Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality
- Lancet: Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial
- Low-Dose Aspirin for the Prevention of Preeclampsia | Guidelines | JAMA | JAMA Network
- Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and opportunities for quality improvement – ScienceDirect
- Hypertensive disorders of pregnancy and long-term risk of maternal stroke—a systematic review and meta-analysis – American Journal of Obstetrics & Gynecology (ajog.org)
- Aspirin Dosing Considerations: Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? – ScienceDirect
- Aspirin in Pregnancy : Obstetrics & Gynecology (lww.com) – Dec 2023 ACOG Green Journal
- The etiology of preeclampsia – ScienceDirect
Shareable PSAs for Social Media
